PET imaging of mGluR5 in Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

PET imaging of mGluR5 in Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

PET imaging of mGluR5 in Alzheimer’s disease

Metabotropic glutamate subtype 5 receptors (mGluR5) modulate synaptic transmission and may constitute an important therapeutic target in Alzheimer’s disease (AD) by mediating the synaptotoxic action of amyloid...

Authors:Adam P. Mecca, Julia W. McDonald, Hannah R. Michalak, Tyler A. Godek, Joanna E. Harris, Erika A. Pugh, Emily C. Kemp, Ming-Kai Chen, Arash Salardini, Nabeel B. Nabulsi, Keunpoong Lim, Yiyun Huang, Richard E. Carson, Stephen M. Strittmatter and Christopher H. van Dyck

Citation:Alzheimer's Research & Therapy 2020 12:15

Content type:Research

Published on: 18 January 2020

• ViewFull Text
 
• ViewPDF